.

Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro

LAUR Repository

Show simple item record

dc.contributor.author Najem, Sonia A.
dc.contributor.author Khawaja, Ghada
dc.contributor.author Hodroj, Mohammad Hassan
dc.contributor.author Rizk, Sandra
dc.date.accessioned 2019-12-03T11:47:32Z
dc.date.available 2019-12-03T11:47:32Z
dc.date.copyright 2019 en_US
dc.identifier.issn 1874-4702 en_US
dc.identifier.uri http://hdl.handle.net/10725/11599
dc.description.abstract Background: Colorectal Cancer (CRC) is a common cause of oncological deaths worldwide. Alterations of the epigenetic landscape constitute a well-documented hallmark of CRC phenotype. The accumulation of aberrant DNA methylation and histone acetylation plays a major role in altering gene activity and driving tumor onset, progression and metastasis. Objective: In this study, we evaluated the effect of Suberoylanilide Hydroxamic Acid (SAHA), a panhistone deacetylase inhibitor, and Decitabine (DAC), a DNA methyltransferase inhibitor, either alone or in combination, on Caco-2 human colon cancer cell line in vitro. Results: Our results showed that SAHA and DAC, separately, significantly decreased cell proliferation, induced apoptosis and cell cycle arrest of Caco-2 cell line. On the other hand, the sequential treatment of Caco-2 cells, first with DAC and then with SAHA, induced a synergistic anti-tumor effect with a significant enhancement of growth inhibition and apoptosis induction in Caco-2 cell line as compared to cells treated with either drug alone. Furthermore, the combination therapy upregulates protein expression levels of pro-apoptotic proteins Bax, p53 and cytochrome c, downregulates the expression of antiapoptotic Bcl-2 protein and increases the cleavage of procaspases 8 and 9; this suggests that the combination activates apoptosis via both the intrinsic and extrinsic pathways. Mechanistically, we demonstrated that the synergistic anti-neoplastic activity of combined SAHA and DAC involves an effect on PI3K/AKT and Wnt/β-catenin signaling. Conclusion: In conclusion, our results provide evidence for the profound anti-tumorigenic effect of sequentially combined SAHA and DAC in the CRC cell line and offer new insights into the corresponding underlined molecular mechanism. en_US
dc.language.iso en en_US
dc.title Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro en_US
dc.type Article en_US
dc.description.version Published en_US
dc.author.school SAS en_US
dc.author.idnumber 199829370 en_US
dc.author.department Natural Sciences en_US
dc.description.embargo N/A en_US
dc.relation.journal Current Molecular Pharmacology en_US
dc.journal.volume 12 en_US
dc.journal.issue 4 en_US
dc.article.pages 281-300 en_US
dc.keywords Apoptosis en_US
dc.keywords Colon cancer en_US
dc.keywords Decitabine en_US
dc.keywords Epigenetics en_US
dc.keywords In vitro en_US
dc.keywords Suberoylanilide hydroxamic acid en_US
dc.identifier.doi https://doi.org/10.2174/1874467212666190313154531 en_US
dc.identifier.ctation Najem, S. A., Khawaja, G., Hodroj, M. H., & Rizk, S. (2019). Synergistic effect of epigenetic inhibitors Decitabine and Suberoylanilide Hydroxamic acid on colorectal Cancer in vitro. Current molecular pharmacology, 12(4), 281-300. en_US
dc.author.email sandra.rizk@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://www.fasebj.org/doi/abs/10.1096/fasebj.2019.33.1_supplement.647.38 en_US
dc.orcid.id https://orcid.org/0000-0002-4405-5703 en_US
dc.author.affiliation Lebanese American University en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR


Advanced Search

Browse

My Account